People: Anthera Pharmaceuticals Inc (ANTH.W)
0.55USD
7 May 2013
$-0.08 (-12.70%)
$0.63
$0.55
$0.55
$0.55
100
389
$3.08
$0.51
Lowe, Christopher
Brief Biography
Mr. Christopher P. Lowe serves as Chief Financial Officer, Chief Business Officer of Anthera Pharmaceuticals Inc., since February 2011. Prior to that time and since November 2007, he served as Chief Financial Officer and Vice President of Administration. Beginning in September 2005 and up until he joined the company, Mr. Lowe served as Vice President of Finance & Administration and, beginning in January 2006, as Chief Financial Officer of Asthmatx, Inc., a medical technology company. Previously, Mr. Lowe was with Peninsula Pharmaceuticals, Inc., as Corporate Controller from June 2004 to October 2004 and Chief Accounting Officer from October 2004 until June 2005. Mr. Lowe holds a B.S. in business administration from California Polytechnic State University, San Luis Obispo and an M.B.A. from Saint Mary’s University, Texas. Mr. Lowe is a director of Hansen Medical Corporation, a medical device company.
Basic Compensation
| Total Annual Compensation, USD | Long-Term Incentive Plans, USD | All Other, USD | Fiscal Year Total, USD |
|---|---|---|---|
| 359,968 | -- | 583,124 | 943,092 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | 30,000 | 184,401.00 |
| Name | Fiscal Year Total |
|---|---|
Christopher Henney |
-- |
Paul Truex |
1,486,080 |
Christopher Lowe |
943,092 |
Debra Odink |
622,372 |
Colin Hislop |
936,716 |
Sanford Zweifach |
-- |

